Questions and Answers

Updated May 11, 2022

On March 18, 2022 CDC announced a new competitive cooperative agreement that will provide funding to establish the US Pathogen Genomics Centers of Excellence (PGCoE) network. This website will be updated with questions and answers from applicant calls or emails. If you have any questions regarding Notice of Funding Opportunity (NOFO) CDC-RFA-CK22-2204external icon not addressed here, please send an email to pgcoecoag@cdc.gov. The deadline for submitting questions for posting to Q&A is May 1. Q&A updates will be posted to this website and published at grants.gov

Summary of Recent Changes
Update as of May 11
  • Section 1: Overview
    • Questions (1-30) through (1-31) added
  • Section 3: Application
    • Questions (3-55) through (3-61) added


View Previous updates

Section 1: Overview

We are not able to discuss proposal ideas with individual applicants. We can respond to questions submitted by email and also will be holding an informational call on March 31 at 2 pm ET. Phone number 1-866-620-0420; Passcode: 8943360.

Questions and answers from this call will be posted on this page.

Added March 25, 2022

CDC does not intend to release a companion solicitation for data management, coordination, and scientific communication activities. These activities will be supported through this NOFO and should be described within applications that are submitted.

Added April 7, 2022

This NOFO is not limited to any particular pathogens of public health concern.
Work of the network is intended to meet the needs of public health and to align with the strategic direction of CDC programs, and to incorporate new technologies and approaches from the rapidly evolving field of genomics. Therefore, the network and individual PGCoEs are expected to be agile and flexible in identifying, implementing, and amending specific activities, to the extent consistent with the terms of this cooperative agreement. Annually, by way of the PGCoE cooperative agreement continuation planning and process, projects will be evaluated and amended as necessary in light of public health priorities, advancement in the field and emerging issues and infectious threats.

Added April 12, 2022

Questions and Answers from the informational call will be posted on this page.

Added April 12, 2022

Year one is largely focused on a number of landscape analyses and individual site projects. Projects in years two through five would include projects that span multiple PGCoEs or are network-wide. Please see page 22 of the NOFO for more details.

Added April 12, 2022

There are a number of different initiatives that span multiple efforts around genomics and workforce development. This is an opportunity to build upon ongoing and synergistic activities; however, this funding opportunity should be considered to be self-standing.

Added April 12, 2022

It is anticipated that six PGCoEs will be funded.

Added April 12, 2022

This NOFO allows both research and non-research activities. This is clarified elsewhere in other sections of the NOFO and supersedes the information on page 48.

Added April 12, 2022

Yes, the mechanism selected is a Cooperative Agreement, this cannot be applied for as a contract.

* Answer updated May 4, 2022

Full question:
Section C (Announcement Type) and section 14 (Funding Restrictions) of the NOFO states that this announcement is only for non-research activities supported by CD. However, in each of these sections, the following paragraph is included: “Please note for this particular NOFO, CDC-RFA-CK22-2204, research activities are allowable and will be subject to all applicable laws, regulations and policy requirements. Note research and human subjects protection requirements inserted throughout this NOFO. All instructions pertaining to research should be addressed and followed as indicated in this NOFO.” Will you confirm that research activities are allowable for CDC-RFA-CK22-2204 (US Public Health Pathogens Genomics Centers of Excellence) and that applications proposing research will be considered?

Answer:
Yes, research activities are allowable for this NOFO. CDC-RFA-CK22-2204 (US Public Health Pathogens Genomics Centers of Excellence) and applications proposing research will be considered. As detailed in H. Other Information the application should describe research and non-research activities for the Mandatory Component (Core) Translation and Response Base strategies and for the Mandatory Component (Response Implementation).

Added April 14, 2022

Funding levels are not guaranteed for any portion of this NOFO. Funding for all components is based on merit review, programmatic priorities, and funding availability.

Added April 20, 2022

The academic institution may use its existing indirect cost rate agreement already in place, provided it has not expired. New indirect cost rate agreements may also be negotiated, and the rate will be determined through that negotiation.

Added April 20, 2022

Although a letter of intent (LOI) is not required, it is helpful for CDC staff to have the information contained within it for the purpose of planning the peer review. The name, address, and telephone number of the PI and any Co-PIs from the applicant health department or public health laboratory should be included in the LOI. The names of all other key personnel, including any Co-PIs from academic or other institutions, should also be included in the LOI.

Added April 20, 2022

Preapplication coordination is required. Environmental impact information is not required for this program. This program is eligible for coverage under E.O. 12372, “Intergovernmental Review of Federal Programs.” An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. 

Added April 27, 2022

Co-Principal Investigator. Each Center of Excellence will have a Principal Investigator from the public health department or public health laboratory (prime recipient) and a Co-Principal Investigator at the partner organization(s). 

Added April 27, 2022

Funds will be awarded by CDC to the prime recipient (health department or public health laboratory) only. The prime recipient will establish sub-award(s) to the academic partner(s). 

Added April 27, 2022

Letters of Intent will not be shared during the application phase.

Added April 27, 2022

The NIH cap is applicable to all CDC awards. 

Added April 29, 2022

No. The amount listed in the NOFO is the maximum amount that will be funded.  

 Added May 4, 2020 

A contract with the academic partner(s) are preferable but we will evaluate other arrangements on a case-by-case basis. 

Added May 4, 2020 

 

There is no set frequency required. However, recipients should not maintain more than 3 days’ worth of federal funding in their interest-bearing bank accounts. 

Added May 4, 2020 

 

We do not recommend withdrawing lump sums. However, recipients should follow their own internal policies. 

Added May 4, 2020 

 

We do not recommend providing lump sums to partners. However, recipients should follow their own internal policies. 

Added May 4, 2020 

 

All HHS grants management policies and guidelines including those in the 2 CFR 200 are applicable. 

Added May 4, 2020 

 

Any additional requirements will be provided at the time of award via the notice of grant award. 

Added May 4, 2020 

 

The NIH cap is applicable to all CDC awards. 

Added May 4, 2020 

 

Federal guidelines allow the CDC assignee to provide assistance in support of this activity by providing factual information consistent with their assignment to the health department. This assistance is consistent with the employee’s duties and does not require further Agency review.

As a Federal employee, the employee’s name may not be listed on any section of the application. Nor is the employee allowed to be a named participant in the execution of related grant activities. Additionally, the employee must refrain from taking any action to influence or represent the interest of the health department in the grant application.

Added May 4, 2020 

We do allow fixed price budgets. However, recipients should follow their own internal policies.

Added May 4, 2022

A letter of intent is recommended but not required. An application can be submitted even if a Letter of Intent was not.

Added May 4, 2020

Decisions to apply are up to the applicant. Applications will be funded based on the review criteria listed in the NOFO, programmatic relevance, and funds availability. Section E. Review and Selection Process (page 57) includes the following Strategy-specific review criterion for the Mandatory Component (Core) – Translation: “Does the applicant (health department) have at least one year of experience with sequencing using next generation methods?”   

Added May 11, 2020

The deadline for application submission is 11:59 pm on May 17, 2022. No extensions are allowed. 

Added May 11, 2020

Section 2: Eligibility

Eligibility criteria can be found on page 35.  U.S. state, local, Tribal, or territorial public health departments or public health laboratories are eligible to be prime recipients. Applications should be submitted by the intended prime recipient. For each site the cooperative agreement will be with one prime recipient, which needs to be a health department. A single CoE may include more than one health department, but a single health department will be the prime recipient. Our intent is that each CoE be a true partnership between the public health agency and its academic partners.  The intent is not that the public health agency act solely as a sub-award manager.

Added March 29, 2022

This NOFO has been published as a domestic opportunity, therefore foreign entities are not eligible to apply. However, we encourage you to continue accessing grants.gov for opportunities that address global needs.

Added March 29, 2022

A single CoE may include more than one health department, but a single health department will be the prime recipient.

Added March 29, 2022

Eligibility criteria can be found on page 35.  U.S. state, local, Tribal, or territorial public health departments or public health laboratories are eligible to be prime recipients.

Added March 29, 2022

The PGCoE is specifically meant to be a partnership between a health department and academia. There may be opportunities to involve industry as well, but the primary structure of the PGCoE is a partnership between a health department and an academic institution.

Added April 12, 2022

Eligibility criteria can be found on page 35. U.S. state, local, Tribal, or territorial public health departments or public health laboratories are eligible to be prime recipients. If an FRFCC is a research organization with expertise in areas relevant to the cooperative agreement, they would be eligible to be an academic partner. FFRDCs operate under specific rules regarding the types of Federal funding they can accept and would need to consult with their own legal counsel regarding serving as an academic partner for this cooperative agreement.

Added April 7, 2022

Applicants may propose inclusion of entities in addition to the prime recipient and primary academic partner(s). Such proposals will be reviewed and considered; however, it is expected that inclusion of additional entities will not dilute the primary partnership between a public health department or public health laboratory and the primary academic partner(s).

Added April 8, 2022

As described on page 28, the applicant (specifically the health department) should have at least one year of sequencing experience.  At least one year of sequencing experience by the public health laboratory is expected for applicants.

Added April 12, 2022

Eligibility requires the prime recipient to be a health department or public health laboratory that must partner with an academic partner or partners.

Added April 12, 2022

The intent of the NOFO is to have the health department as the prime recipient partnering with an academic partner or partners. Multiple levels of subcontracts are not encouraged to avoid creating a passthrough entity, which is not allowed.

Added April 12, 2022

The capacity of the laboratory or partner to complete the work will be evaluated as part of the application review process. It is not the size of the laboratory or partner per se that will be evaluated but rather having the important capabilities needed that are detailed in the NOFO. Please see page 28 for specific expectations of laboratory capacity for the prime recipient: “Sequencing using next generation sequencing methods. Applicants (specifically, the public health department) should have at least one year of sequencing experience.”

Added April 12, 2022

U.S. state, local, tribal, or territorial public health departments or public health laboratories are eligible to be prime recipients. It is not a requirement that public health laboratories be embedded within health department.

Added April 14, 2022

Each Center of Excellence will have a principal investigator from the public health department or public health laboratory (prime recipient) and the partner organization(s). 

Added April 14, 2022

The Centers of Excellence program was originally conceived of and budgeted to support a single health department paired with a single academic research center at each funded site. However, in recognition that there may be advantages in some cases for there to be more than two entities at certain sites, the funding opportunity allows applicants to propose including more than one academic or more than one public health organization. Such proposals will be reviewed and considered. However, any such arrangement should be organized in such a way that within the proposed site, both the public health and academic partners can contribute meaningfully to the partnership. The objective of the program is not to establish a network of sub-networks, with each of those sub-networks doing research disconnected from that being carried out by the others; rather the objective is to establish a network of a small number of sites, each an active partnership, with each site working collaboratively with other sites in the network to improve public health and public health practice.

Added April 14, 2022

Eligibility criteria can be found on page 35. U.S. state, local, Tribal, or territorial public health departments or public health laboratories are eligible to be prime recipients. The primary partner(s) for the public health department or public health laboratory at each Pathogen Genomics Center of Excellence will be an academic institution(s).

This NOFO does not restrict academic partners to specific universities or other specific institutions. Applications should be submitted by the intended prime recipient. Applications should include input from both the public health agency and their intended academic partner(s).

Added April 14, 2022

Eligibility criteria can be found on page 35. U.S. state, local, Tribal, or territorial public health departments or public health laboratories are eligible to be prime recipients for both Mandatory and Optional Components of this NOFO. Recipients are expected to collaborate with one or more academic centers with strong programs in pathogen genomics or genomic epidemiology for all components (Mandatory and Optional).

Added April 14, 2022

Our intent is for the health department or laboratory (prime recipient) and each academic partner, if there is more than one, to form a true partnership. In recognition that there may be advantages in some cases for there to be more than two partners at certain sites, the funding opportunity allows applicants to propose including more than one academic or more than one public health organization. Such proposals will be reviewed and considered. However, any such arrangement should be organized in such a way that within the proposed site, both the public health and academic partners can contribute meaningfully to the partnership.

Added April 14, 2022

501 (c) (3) organizations whose primary mission is research may serve as partners to the prime recipient (public health department or public health laboratory).

Added April 14, 2022

The governmental applicant is not required to hold the majority of the funds. Please note that the health department cannot play merely as a “pass-through” entity in the partnership. The intent is that the health department plays a substantial and meaningful role in the partnership.

Added April 14, 2022

The primary partner(s) for the public health department or public health laboratory at each Pathogen Genomics Center of Excellence will be an academic institution(s). Industry laboratories are not able to serve as the primary partner to a public health department or public health laboratory.

Added April 14, 2022

This NOFO has been published as a domestic opportunity; therefore, foreign entities are not eligible to be prime recipients or primary academic partners.

Applicants may propose inclusion of entities in addition to the prime recipient and primary academic partner(s). Proposals may include foreign entities. Such proposals will be reviewed and considered; however, it is expected that inclusion of additional entities will not dilute the primary partnership between a public health department or public health laboratory and the primary academic partner(s).

Added April 20, 2022

Our intent is for the health department or laboratory (prime recipient) and each academic partner, if there is more than one, to form a true partnership. In recognition that there may be advantages in some cases for there to be more than two partners at certain sites, the funding opportunity allows applicants to propose including more than one academic or more than one public health organization. Such proposals will be reviewed and considered. However, any such arrangement should be organized in such a way that within the proposed site, both the public health and academic partners can contribute meaningfully to the partnership.

Added April 20, 2022

The applicant must be a US state, local, Tribal, or territorial public health department or public health laboratory and must partner with at least one academic institution. There is no limit to the number of partners the recipient may have provided each partner has a meaningful and productive role.

The Centers of Excellence program was originally conceived of and budgeted to support a single health department paired with a single academic research center at each funded site. However, in recognition that there may be advantages in some cases for there to be more than two entities at certain sites, the funding opportunity allows applicants to propose including more than one academic or more than one public health organization. Such proposals will be reviewed and considered. However, any such arrangement should be organized in such a way that within the proposed site, both the public health and academic partners can contribute meaningfully to the partnership. The objective of the program is not to establish a network of sub-networks, with each of those sub-networks doing research disconnected from that being carried out by the others; rather the objective is to establish a network of a small number of sites, each an active partnership, with each site working collaboratively with other sites in the network to improve public health and public health practice.

Added April 20, 2022

The PGCoEs are expected to operate collaboratively as a network. One organization may collaborate with more than one state health department; however, the collaborating organization must not duplicate percent effort or budget with two or more recipients. Should applications from the multiple state health departments be selected for award, the collaborating organization’s involvement in multiple awards will be assessed for possible overlap.

Added April 20, 2022

The applicant must be a US state, local, Tribal, or territorial public health department or public health laboratory which has at least one academic partner. It is the applicant’s responsibility to establish collaborations with at least one academic partner and to administer the funds received post-award. The health department may be able to use a fiscal agent to help the health department administer the funds after award on a case-by-case basis. The health department must include this intent in the application.

Added April 20, 2022

The only eligible applicants are US state, local, Tribal, or territorial public health departments or public health laboratories; multiple Co-PIs are allowed and there must be one PI from the applicant institution serving as the point of contact for all award-related actions and one from the primary academic partner at a minimum. Co-PIs may be situated at the applicant institution or at any of the collaborating institutions.

Added April 20, 2022

Eligibility criteria can be found on page 35.  U.S. state, local, Tribal, or territorial public health departments or public health laboratories are eligible to be prime recipients.

Added April 27, 2022

The IPA assignee may participate as long as there is no overlap of IPA activities, percent effort, or funding received with that under the NOFO. Also, the IPA assignee must not use their IPA position/CDC affiliation to influence the design of the studies or direct how the activities/work related to the award will be conducted/supported or sway judgement/decisions that would otherwise have been made without coercion. Please keep in mind that although IPA assignees are not CDC employees, they are still held to the same Standards of Ethical Conduct as CDC employees while participating on the IPA assignment. 

Added April 27, 2022

The academic partner is intended to be an academic institution but one person from an academic institution can collaborate with more than one PGCoE provided there is no scientific, budgetary or percent effort overlap by the individual to the two centers. 

Added May 4, 2022 

Recipients should adhere to their internal procurement policies and in accordance with 45 CFR 75.329 Procurement procedures. 

Added May 4, 2022 

Section 3: Application

For the Mandatory Component (Core) Education strategy, activities expected for this strategy are described on page 15 and those expected for the Optional Component (Lead PGCoE for education) are described on page 18. A landscape analysis is not required for the Mandatory (Core) education strategy. Applicants are not required to use the performance measures listed on page 23. The Performance Measures listed for “Educate Public Health Workforce” may be used as applicable to a particular application’s Mandatory Component (Core) Education strategy or, if included in the application, Optional Component (Lead PGCoE for Education).

Added April 12, 2022

There is no required format for resumes or CVs. Resumes and CVs do not count against the page limit.

Added April 12, 2022

The narratives for the Mandatory Components (Core, Response Implementation) should be submitted as a single file as detailed on page 72.

Added April 12, 2022

References are only required for the Project Narrative for the Mandatory Component (Core) strategy Translation. References do count toward the total page count of the narrative.

Added April 12, 2022

A separate work plan must be provided for each of the Components. For each component, the applicant must provide detailed work plan for the first year and a high-level work plan for subsequent years.  For the Mandatory Component (Core) the work plan must be divided by strategy. The Mandatory Component (Core) has three strategies: Translation, Education, and Response Base. For the Mandatory Component (Core) strategies Translation and Response Base and for the Mandatory Component (Response Implementation), there should be a separate work plan for each of the 5 broad areas as described on pages 69-70. Activities proposed under the respective work plans must align with the approach (logic model, strategies, outcomes, and evaluation/performance measures) outlined throughout the NOFO. A sample table format for a work plan is shown on page 30. No specific work plan format is required, as long as it is clear how the components in the work plan crosswalk to the strategies and activities, outcomes, and evaluation and performance measures presented in the logic model and the narrative sections of the NOFO. This will ensure that the applicant sees the work plan as proceeding from what was presented earlier and not as a separate, standalone document.  

* Answer updated April 27, 2022

Full Question:

For the Mandatory Component (Core) strategy Translation, for example, pages 69-70 of the NOFO specify a list of sections that should be included for each of the 5 broad areas. Therefore, our understanding is that the headings for this component narrative should look like this:

  • Broad Area 1 (wet lab methods)
  • Background
  • Activities (with 11 required subheadings)
  • Resource Sharing Plan
  • Evaluation and Performance Measurement Plan
  • Organizational Capacity
  • Work Plan
  • Bibliography
  • Broad Area 2 (bioinformatics)
  • Background
  • Activities (with 11 required subheadings)
  • Broad Area 3 (data standardization, etc.)
  • Background
  • Activities (with 11 required subheadings)
  • etc.

Under this structure, we would submit 5 different work plans within the Project Narrative for the Translation strategy of the Mandatory Component (Core).   Similarly, the NOFO states that the “Approach” subsection (listed under the “Activities” section) should contain the IRB plan. Does that mean we should include 5 separate IRB plans, one within each broad area section? What is the correct structure of this Project Narrative? This same question applies to the Project Narrative for the Mandatory Component (Core) strategy Response Base and Mandatory Component (Response Implementation), which also require multiple separate sections for each broad area (background, approach, evaluation plan, organizational capacity, work plan; pages 70 and 71).

Answer:
The Narrative for the Mandatory Component (Core) strategy Translation should be organized according to the 5 broad areas listed on page 69. For each of these 5 broad areas, the narratives should be organized by sections in the list of 7 bullets and 11 sub-bullets that begins with “Background” and ends with “Bibliography and References.” This means that a separate IRB plan should be provided for each of the 5 broad areas of the Mandatory (Core) Translation strategy. A separate work plan must be provided for each of the Components. For the Mandatory Component (Core) the work plan must be divided by strategy. For the Mandatory Component (Core) strategy Translation, there should be a separate work plan for each of the 5 broad areas as described on pages 69-70. For the Mandatory (Core) strategy Response Base and Mandatory Component (Response Implementation) the narratives should be organized into the 5 broad areas described on page 70 and within each of those 5 broad areas the narrative should include the 5 sections: Background, Approach, Application Evaluation and Performance Plan, Organizational Capacity of Applicants to Implement the Approach, and Work Plan. For the Mandatory (Core) strategy Education and for the Optional Component (Lead PGCOE for Education) the narrative should be organized into the 5 sections: Background, Approach, Application Evaluation and Performance Plan, Organizational Capacity of Applicants to Implement the Approach, and Work Plan.

Added April 12, 2022

This is correct.
For the Mandatory Component (Core) Translation strategy, each of the five broad areas listed should have a detailed description of the seven sections listed on pages 69-70.
The seven sections are
1) Background
2) Activities (note, this section has 11 sub-sections)
3) Resource Sharing Plan (including Data Management Plan)
4) Evaluation and Performance Measurement Plan
5) Organizational Capacity of Applicant to Implement the Approach (Including Investigator qualifications and institutional Environment to successfully complete objectives)
6) Work Plan
7) Bibliography and References Cited

Added April 12, 2022

Separate work plans must be provided for each of the Components. For the Mandatory Component (Core) the work plan must be divided by strategy.  For the Mandatory Component (Core) strategies Translation and Response Base and for the Mandatory Component (Response Implementation), there should be a separate work plan for each of the 5 broad areas as described on pages 69-70.

* Answer updated April 27, 2022

The budget submitted should include both direct and indirect costs. No additional indirect costs will be added to the budget once submitted.

Added April 12, 2022

There is not a page limit for budgets. Please see page 72 of the NOFO for instructions on page limits for the narratives (which include work plans):

PAGE LIMIT:
Disregard page limits stated under Section D.10 for “Program Narrative,” (but do follow other page and type format instructions).
Maximum number of pages for the Mandatory Components (Core, Response Implementation) Project Narrative file is 75 (excluding budget, budget narrative, appendices, and required forms). Maximum number of pages for the Optional Component (Lead PGCoE for Education) is 25 (excluding budget, budget narrative, appendices, and required forms). If Project Narrative exceeds the page limit, only the first pages which are within the page limit will be reviewed. 

Added April 14, 2022

There is no page limit for attachments. 

Added April 14, 2022

All letters of support from academic partners should be submitted as a single PDF file entitled “Academic Letter of Support.” Additional letters of support may be provided as attachments.

The Centers of Excellence program was originally conceived of and budgeted to support a single health department paired with a single academic research center at each funded site. However, in recognition that there may be advantages in some cases for there to be more than two entities at certain sites, the funding opportunity allows applicants to propose including more than one academic or more than one public health organization. Such proposals will be reviewed and considered. However, any such arrangement should be organized in such a way that within the proposed site, both the public health and academic partners can contribute meaningfully to the partnership. The objective of the program is not to establish a network of sub-networks, with each of those sub-networks doing research disconnected from that being carried out by the others; rather the objective is to establish a network of a small number of sites, each an active partnership, with each site working collaboratively with other sites in the network to improve public health and public health practice.

Added April 14, 2022

The Academic Letter of Support should be addressed to the applicant.

Added April 20, 2022

Please see page 72 of the NOFO for instructions on page limits for the narratives (which include work plans): “Disregard page limits stated under Section D.10 on page 43 for “Program Narrative,” (but do follow other page and type format instructions).

The maximum number of pages for the Project Narrative file (which includes workplans) for the two Mandatory Components (Core, Response Implementation) combined is 75 (excluding budget, budget narrative, appendices, and required forms). Maximum number of pages for the Optional Component (Lead PGCoE for Education) is 25 (excluding budget, budget narrative, appendices, and required forms).

If an applicant chooses to apply only for the Mandatory Components (Core, Response Implementation) the total page limit for the application Narrative (which includes work plans) is 75 pages. If an applicant chooses to apply for both the Mandatory Components (Core, Response Implementation) and Optional (Lead PGCoE for Education) Component the total page limit for the application Narratives (which includes work plans) is 100 pages. There are no page limits for other sections of the application.

Added April 19, 2022

This is a question that should be directed to the grants.gov helpdesk, as this is more of a systems and access question and does not relate directly to the content of the Notice of Funding Opportunity. A link to the support desk is below:

d. Technical Difficulties: If technical difficulties are encountered at www.grants.gov, applicants should contact Customer Service atwww.grants.gov. The www.grants.gov Contact Center is available 24 hours a day, 7 days a week, except federal holidays. The Contact Center is available by phone at 1-800-518-4726 or by e-mail at support@grants.gov. Application submissions sent by e-mail or fax, or on CDs or thumb drives will not be accepted. Please note that www.grants.gov is managed by HHS.”

Added April 20, 2022

Estimated funding levels for subsequent years should be indicated on application form SF242a in sections 16b, c, d, and e.

Added April 20, 2022

The only elements needed for the project narrative are the ones outlined in Section H, pages 69-71, of the NOFO.

Added April 20, 2022

For the Mandatory Component (Core) Translation strategy there is not a requirement to do one research and one non-research activity for each of the 5 broad topic areas; but within each of the 5 broad topic areas proposed activities should include both research and non-research activities. Detailed instructions for the Narrative section are in Section H. Other Information of the NOFO. The activities proposed under each of the 5 topic areas should address areas of activity specified in the logic model and detailed on pages 12-16. Activities should include contribution toward a landscape analysis in each of the 5 broad topic areas.

Added April 20, 2022

The Mandatory Component (Core) Translation strategy, the Mandatory Component (Core) Response Base strategy, and the Mandatory Component (Response Implementation) should include a research project or projects and should also include non-research projects. Projects should address the 5 broad topic areas.

The Mandatory Component (Core) Education strategy and the Optional Component (Lead PGCoE Education) may not include a research project or projects.

Added April 20, 2022

Yes. If there is nothing to disclose the form should be completed and signed to verify that there is nothing to disclose.

Added April 20, 2022

The format for the narratives should follow the instructions in H. Other Information starting on page 69. The yellow boxes in section E. Review and Selection Process, beginning on page 51, detail review criteria that will be used to evaluate applications during Phase II review.  It is best to address the elements listed as Review Criteria, as well as those for Additional Review Criteria (i.e., Human Subjects and Vertebrate Animals; Inclusion of Women, Minorities, and Across the Lifespan; Biohazards/Dual Use Research of Concern), found on pages 52-57 when completing the Activities sections of the same name in H. Other Information (as applicable) for each of the 5 broad areas of the Mandatory Component (Core) because these criteria could influence the score the application receives.

Added April 20, 2022

For the Narrative sections for Mandatory (Core) Translation strategy, Mandatory (Core) Response Base strategy, and Mandatory Component (Response Implementation) there should be separate sections for Background, Approach, Application Evaluation and Performance Plan, Organizational Capacity for the Applicant to Implement the Approach, and Work Plan within each of the 5 broad topic areas (wet laboratory, bioinformatics technologies, etc.).  For the Mandatory Component (Core) strategy Translation only, there should in addition be 11 sub-sections (Purpose, Outcomes, Significance, etc.) for the Activities sections. 

Added April 27, 2022

The budget submitted should include both direct and indirect costs. No additional funds will be made available to offset indirect costs. 

Added April 27, 2022

Subaward budgets to the academic partner should be described in budget narratives in separate budgets.

Added April 27, 2022

For the Mandatory Components, there should be a single file entitled “Budget Narrative” that includes individual and complete line item budgets and detailed justification narratives for each of the following: 1) Mandatory Component (Core) strategy Translation, 2) Mandatory Component (Core) strategy Education, 3) Mandatory Component (Core) strategy Response Base, 4) Mandatory Component (Response Implementation). Budget narratives should be sub-divided by the 5 topic areas. 

Added April 27, 2022

A detailed budget for the first year for each of the Mandatory Components (and for each strategy of the Mandatory Component (Core)) should be provided. For each detailed Budget line item, justification should be provided in the Budget Narrative. 

Total anticipated funding level should be indicated for years 2-5 in the budget and on Form 424A application form SF242a in sections 16b, c, d, and e. 

Added April 27, 2022

A detailed budget for each of the Mandatory Components (and for each strategy of the Mandatory Component (Core) should be provided. For each detailed Budget line item, justification should be provided in the Budget Narrative. 

Added April 27, 2022

There is not a requirement for a certain number of projects. For Mandatory Component (Core) strategies Translation and Response Base and for Mandatory Component (Response Implementation), activities should include research and non-research, and research activities should be proposed within each of the 5 broad topic areas. Activities may be organized within or across topic areas and may span different strategies. 

Added April 27, 2022

Form 424A should be completed for years 1-5. 

Added April 27, 2022

On SF-424A limited detail can be included. A single form is used for all Components (Mandatory and Optional).  

Please see section 12. Budget Narrative of the NOFO for information on detailed budget items that should be included in the Budget Narrative (for example, percent time, salary, fringe benefits, etc.).

Added April 27, 2022

The only letter that is required is from an academic partner(s) showing willingness to partner with the prime recipient. It should be signed by the Principal Investigator from the academic partner(s). All letters of support should be addressed to the prime applicant Principal Investigator at the health department or public health laboratory. 

Added April 27, 2022

Year one is largely focused on a number of landscape analyses and individual site projects. Projects in years two through five would include projects that span multiple PGCoEs or are network-wide. Please see page 22 of the NOFO for more details.                                       

Estimated funding levels for years 2-5 should be indicated on application form SF242a in sections 16b, c, d, and e. 

Added April 27, 2022

The health department’s Institutional Review Board (IRB) may be used as the IRB of Record (i.e., the single IRB) as long as that IRB is registered with the Office for Human Research Protections (OHRP) and agrees to accept that responsibility. The partner(s) would need to enter into a written agreement with the health department in order to rely on that IRB for protocol review.   

Information regarding a single IRB plan should be included under “Activities” as specified in the H. Other Information section (p. 69) and as further detailed on pp. 48-49 of the NOFO. Additional information regarding the single institutional review board (IRB) plan and format can be found at https://grants.nih.gov/grants/how-to-apply-application-guide/forms-g/general-forms-g.pdfpdf iconexternal icon referenced on p. 11 of the NOFO. 

Added April 29, 2022

This form should be completed for all personnel that will have a key role on the award. This form is not limited to the personnel listed. 

Added April 29, 2022

The period of performance covers the entire 5 years of the NOFO.

Added May 4, 2022 

Please note an Evaluation and Performance Measurement Plan must be provided for each of the 5 broad areas for Mandatory Component (Core) Translation strategy and Response Base strategy and for the Mandatory Component (Response Implementation).

For portions of the application that are redundant, a detailed description may be provided once and then referenced throughout along with any additional information specific to a particular section.

Added May 4, 2022

One organization may collaborate with more than one state health department; however, the collaborating organization must not duplicate percent effort, budget, or scientific activity with two or more recipients. Should applications from the multiple state health departments be selected for award, the collaborating organization’s involvement in multiple awards will be assessed for possible overlap.

Added May 4, 2022

Subaward budgets of the academic partner should be described in separate budget narratives as part of the prime recipient’s application.

Added May 4, 2022

The health department’s Institutional Review Board (IRB) may be used as the IRB of Record (i.e., the single IRB) as long as that IRB is registered with the Office for Human Research Protections (OHRP) and agrees to accept that responsibility. The partner(s) would need to enter into a written agreement with the health department in order to rely on that IRB for protocol review.

Information regarding a single IRB plan should be included under “Activities” as specified in the H. Other Information section (p. 69) and as further detailed on pp. 48-49 of the NOFO. Additional information regarding the single institutional review board (IRB) plan and format can be found at https://grants.nih.gov/grants/how-to-apply-application-guide/forms-g/general-forms-g.pdfpdf iconexternal icon referenced on p. 11 of the NOFO.

Added May 4, 2022 

For portions of the application that are redundant, a detailed description may be provided once and then referenced throughout along with any additional information specific to a particular section.

Added May 4, 2022

For Mandatory Component (Core) Response Base strategy and for Mandatory Component (Response Implementation) the project narrative should be separated into 5 broad areas (wet laboratory, bioinformatics, etc.). For each of these 5 broad categories, the narrative should have the following sections: Background, Approach, Application Evaluation and Performance Plan, Organizational Capacity of Applicants to Implement the Approach, Work Plan.

For the Mandatory Component (Core) Translation strategy only, there should in addition be 11 sub-sections (Purpose, Outcomes, Significance, etc.) for the Activities sections.

Added May 4, 2022

SF-424A should be divided by component (e.g., there should be separate columns for Mandatory Component (Core), Mandatory Component (Response Implementation), Optional Component (Lead PGCoE for Education)).

Added May 4, 2022

For portions of the application that are redundant, a detailed description may be provided once and then referenced throughout along with any additional information specific to a particular section.

In the budget narrative, the PIs percent effort should be delineated for each of the broad topic areas.

Added May 4, 2022

The risk assessment only needs to be completed by the prime recipient.

Added May 4, 2022

A letter of support from an academic partner(s) is required. Additional letters of support from collaborating entities may be provided. All letters of support from academic partners should be submitted as a single PDF file entitled “Academic Letter of Support.” Additional letters of support may be provided as attachments.

Added May 4, 2022

Yes, but it must be included in the page limit.

Added May 4, 2022

The landscape analysis should be incorporated into each of the 5 broad sections of Mandatory Component (Core) Translation strategy.

Added May 4, 2022

These documents must be provided at the time of application.

Added May 4, 2022

Yes. For portions of the application that are redundant, a detailed description may be provided once and then referenced throughout along with any additional information specific to a particular section.

Added May 4, 2022

The applicant must provide a detailed work plan for the first year and a high-level work plan for subsequent years.

Added May 4, 2022

This form should be completed for all personnel that will have a key role on the award. This form is not limited to the personnel listed.

Added May 4, 2022

Full question:
The NOFO instructs that several documents should be divided into the 5 broad areas specified. When dividing the document into Broad Area sections, do we need to include the full title of the Broad Area or would it be sufficient to just use numbers or abbreviated names?

For example, must we write: “Broad Area 3: Data standardization/data security/data stewardship/data integration and reporting/data linkage/data science/data analytics/data visualization including of genomic, epidemiologic, clinical, biological, environmental, geospatial, behavioral, social and other types of data together” each time or could we instead call the section simply “Broad Area 3” or “Broad Area 3: Data?”

Answer:
The 5 Broad Areas may be defined in the application with a number (Broad Area 3), or with a number and shortened term (Broad Area 3: Data), or with a shortened term alone (Data) to describe these Broad Areas.

Added May 4, 2022

Yes, each component will have its own column and should be labeled accordingly for a total of $7M, if applying for the Optional Component.

A detailed breakdown should be included on the budget narrative document.

Added May 4, 2022

Recipients must adhere to the terms of their negotiated indirect cost rate agreement. If utilizing a Modified Total Direct Cost (MTDC) indirect cost model, they must include the first $25k for each subawards. If issuing only one subaward the allowance is limited to the first $25K for that subaward.

Added May 4, 2022

Applicants should propose an initial research and non-research project or projects that include all 5 broad topic areas. These may be organized as separate projects for the 5 different topic areas or as a single project or projects that include activities for the 5 broad topic areas. The format for the Project Narrative should follow the format described in the H. Other Information section of the NOFO for the Mandatory Component (Core) strategy Translation. 

Added May 11, 2022

Applications should describe the Personnel, Environment, and Management and Administrative capacities in the Project Narrative under the headings for “Organizational Capacity of Applicant to Implement the Approach” (see H. Other Information section of the NOFO). 

Added May 11, 2022

The example Work Plan headers are correct as formatted on p. 30 of the NOFO. 

Added May 11, 2022

There will be two coordinating group meetings each year beginning in budget year 1. We expect that one of these meetings will be held in conjunction with the Annual Network Meeting. Each meeting is expected to last approximately 3-4 days.   

Added May 11, 2022

Yes, the data management plan (DMP) is included in the page count and should not be added as an appendix. Please note that at the time of application submission, a high-level plan is required that addresses the bullets listed in the DMP section on page 26 of the NOFO. Award recipients have 6 months to finalize a detailed DMP. 

Added May 11, 2022

The Project Narratives for the Mandatory Component (Core) and Mandatory Component (Response Implementation) have a combined limit of 75 pages. 

Added May 11, 2022

Yes.

Added May 11, 2022

Section 4: Response Implementation

The Mandatory Component (Response Implementation) will only be funded and implemented when and if there is a need to respond to an infectious threat. As described on page 16, applications should describe the types of experiments, research studies, and non-research activities that could be done in the event of an infectious threat. Applications should include working with other network sites to analyze and synthesize pathogen genomic and other diverse data and preparing informational reports.  Applications should also describe implementation activities in the five broad areas listed.

Added April 12, 2022

This NOFO is to establish a platform for pathogen genomics and innovation in the US. Response implementation should involve collaboration with CDC and CDC programs and is meant to be a broad and flexible platform that can be adapted for use with a specific pathogen or pathogens.

Added April 12, 2022

The Mandatory Component (Response implementation) will only be funded and implemented when and if there is a need to respond to an infectious threat.

* Answer updated May 4, 2022

There are two parts to the answer:
1) Within the Mandatory Component (Core), there are funds to build a Response Base to prepare for an infectious disease threat. For example, this could include establishing data use agreements, protocols, operating procedures, and planning for a response to an infectious disease threat.
2) There is a separate Mandatory Component (Response Implementation) that would be activated if there is an actual infectious disease threat. The Response Implementation Component would be activated according to whatever disease threat is present at the time. In the NOFO, “Section H. Other Information” details some of the elements that should be included in the application’s Project Narrative. This includes activities that could be stood up in a flexible way depending on what the actual infectious disease threat is, includes the five broad areas of work listed in this section of the NOFO, and includes activities that might be needed such as genomic sequencing, bioinformatics, rapidly analyzing diverse data and synthesizing information, etc.

Added April 12, 2022

Funding levels are not guaranteed for any portion of this NOFO. Funding for all components is based on merit review, programmatic priorities, and funding availability.

A separate budget and budget narrative, including the estimated cost and percent effort of personnel, is required for each component: Mandatory Component (Core), Mandatory Component (Response Implementation) and Optional Component (Lead PGCoE Education – if applied for).

In the event of an emerging infectious threat and the need to respond, successful Mandatory Component (Core) recipients will be notified and will be requested to submit a revised budget based on the available funds.

Added May 4, 2022

Section 5: Academic Partners

The academic institution can use the existing indirect cost rate it now uses as long as the indirect cost rate agreement has not expired.

Added April 12, 2022

An “Academic Letter of Support” from the partnering academic organization(s) should articulate the nature of the partnership and the partner’s commitment to participate in the proposed activities.

Added April 7, 2022

A health system that is a teaching institution would be considered an academic institution. The academic partner for a CoE is expected to be an entity with expertise in microbial genomics and genomic epidemiology.

Added April 7, 2022

The Centers of Excellence program was originally conceived of and budgeted to support a single health department paired with a single academic research center at each funded site. However, in recognition that there may be advantages in some cases for there to be more than two entities at certain sites, the funding opportunity allows applicants to propose including more than one academic or more than one public health organization. Such proposals will be reviewed and considered. However, any such arrangement should be organized in such a way that within the proposed site, both the public health and academic partners can contribute meaningfully to the partnership. The objective of the program is not to establish a network of sub-networks, with each of those sub-networks doing research disconnected from that being carried out by the others; rather the objective is to establish a network of a small number of sites, each an active partnership, with each site working collaboratively with other sites in the network to improve public health and public health practice.

Added April 7, 2022

Update as of May 4

  • Section 1: Overview
    • Response (1-9) updated
    • Questions (1-30) through (1-31) added
  • Section 2: Eligibility
    • Questions (2-29) and (2-30) added
  • Section 3: Application
    • Responses to (3-5) and (3-8) updated
    • Questions (3-55) through (3-61) added
  • Section 4: Response Implementation
    • Response (4-3) updated
    • Question (4-5) added

Update as of April 29

  • Section 1: Overview
    • Question (1-18) added
  • Section 3: Application
    • Questions (3-33) and (3-34) added

Update as of April 27

  • Section 1: Overview
    • Questions (1-14) through (1-17) added
  • Section 2: Eligibility
    • Questions (2-27) and (2-28) added
  • Section 3: Application
    • Response to (3-5) and (3-8) updated
    • Questions (3-22) through (3-32) added

Update as of April 20

  • Section 1: Overview
    • Questions (1-11) through (1-13) added
  • Section 2: Eligibility
    • Questions (2-21) and (2-26) added
  • Section 3: Application
    • Questions (3-15) through (3-21) added

Note: This page will be updated on Wednesdays and Fridays as of April 20.

Page last reviewed: May 11, 2022